Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Arrail Group Ltd. ( (HK:6639) ) has shared an announcement.
Arrail Group Limited has received formal resumption guidance from the Hong Kong Stock Exchange after its shares were suspended from trading since December 2025 due to delays in financial reporting and related regulatory concerns. The company must complete an independent forensic investigation, address internal control weaknesses, publish all outstanding financial results, and demonstrate regulatory compliance and management integrity by an 18‑month deadline, or risk potential cancellation of its listing.
Management says it is taking steps to meet the exchange’s requirements, including moving to appoint independent internal control consultants to review and strengthen the group’s systems. Trading in the company’s shares will remain suspended while Arrail implements remedial measures and provides mandated quarterly updates to keep shareholders and investors informed about progress on its resumption plan.
The most recent analyst rating on (HK:6639) stock is a Hold with a HK$2.00 price target. To see the full list of analyst forecasts on Arrail Group Ltd. stock, see the HK:6639 Stock Forecast page.
More about Arrail Group Ltd.
Arrail Group Limited is a dental services provider operating through subsidiaries and variable interest entities, with its shares listed on the Hong Kong Stock Exchange. The group focuses on providing professional dental care in mainland China, positioning itself within the broader healthcare and consumer services market.
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.03B
See more insights into 6639 stock on TipRanks’ Stock Analysis page.